Larson Financial Group’s Biogen BIIB Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q2 | $64.9K | Buy |
517
+436
| +538% | +$54.8K | ﹤0.01% | 972 |
|
|
2025
Q1 | $11.1K | Sell |
81
-82
| -50% | -$11.2K | ﹤0.01% | 1583 |
|
|
2024
Q4 | $24.9K | Buy |
163
+141
| +641% | +$21.6K | ﹤0.01% | 1134 |
|
|
2024
Q3 | $4.26K | Sell |
22
-464
| -95% | -$89.9K | ﹤0.01% | 1690 |
|
|
2024
Q2 | $113K | Buy |
486
+277
| +133% | +$64.2K | 0.01% | 616 |
|
|
2024
Q1 | $45.1K | Buy |
209
+173
| +481% | +$37.3K | ﹤0.01% | 712 |
|
|
2023
Q4 | $9.32K | Hold |
36
| – | – | ﹤0.01% | 1037 |
|
|
2023
Q3 | $9.25K | Hold |
36
| – | – | ﹤0.01% | 1019 |
|
|
2023
Q2 | $10.3K | Sell |
36
-87
| -71% | -$24.8K | ﹤0.01% | 923 |
|
|
2023
Q1 | $34.2K | Sell |
123
-8
| -6% | -$2.22K | ﹤0.01% | 623 |
|
|
2022
Q4 | $36.3K | Buy |
131
+38
| +41% | +$10.5K | ﹤0.01% | 581 |
|
|
2022
Q3 | $25K | Buy |
+93
| New | +$25K | ﹤0.01% | 576 |
|
|
2021
Q4 | – | Sell |
-77
| Closed | -$22K | – | 1069 |
|
|
2021
Q3 | $22K | Hold |
77
| – | – | ﹤0.01% | 442 |
|
|
2021
Q2 | $27K | Buy |
+77
| New | +$27K | 0.01% | 385 |
|
|
2020
Q1 | – | Sell |
-4
| Closed | -$1K | – | 541 |
|
|
2019
Q4 | $1K | Hold |
4
| – | – | ﹤0.01% | 490 |
|
|
2019
Q3 | $1K | Hold |
4
| – | – | ﹤0.01% | 469 |
|
|
2019
Q2 | $1K | Hold |
4
| – | – | ﹤0.01% | 422 |
|
|
2019
Q1 | $1K | Hold |
4
| – | – | ﹤0.01% | 417 |
|
|
2018
Q4 | $1K | Buy |
+4
| New | +$1K | ﹤0.01% | 392 |
|